The Subventricular Zone: A Key to Unlocking Neurological Treatments

SHANNON, CLARE, IRELAND, March 4, 2025 /EINPresswire.com/ -- This recently published exploration into the subventricular zone (SVZ) highlights its critical role in neural regeneration, neurodegenerative diseases, and glioblastoma multiforme (GBM). The SVZ, a neurogenic hub of the adult brain, harbors neural stem cells (NSCs) and neural progenitor cells (NPCs), influencing brain repair and disease progression.

The SVZ is a dynamic reservoir of neurogenesis, continuously generating new neurons and glial cells essential for brain plasticity and recovery. Its intricate cellular composition, including ependymal cells, astrocytes, and migrating neuroblasts, enables significant contributions to neural injury repair. In cases of brain damage, SVZ-derived cells can migrate to injured regions, differentiating into specialized neural cells, fostering repair and functional restoration.
In the realm of neurodegenerative diseases, the SVZ plays a complex role. Conditions such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) exhibit alterations in SVZ neurogenesis, impacting disease progression. In AD, amyloid-beta accumulation and tau pathology suppress neural regeneration, while in PD, dopamine depletion disrupts SVZ stem cell function. For HD, increased proliferation in the SVZ is observed, though this fails to counteract the progressive neuronal loss. The potential of stem cell-based therapies targeting the SVZ could offer novel interventions for these devastating conditions.

The connection between SVZ and GBM is particularly striking. The SVZ’s stem cell niche has been implicated in GBM initiation, progression, and resistance to therapy. Glioblastoma cells often originate within or near the SVZ, exploiting its stem cell-like environment to sustain tumor growth and invasiveness. Emerging research suggests that targeting SVZ-related pathways may enhance GBM treatments, potentially overcoming the radioresistance and recurrence that are experienced with conventional therapies.

The therapeutic potential of the SVZ is encouraging, with neural stem cell transplantation, cytokine therapy, and targeted gene interventions emerging as promising strategies. Harnessing the SVZ’s regenerative capacity could revolutionize treatments for brain injuries, neurodegenerative disorders, and aggressive brain tumors. With further advancements, the future of neurology may be shaped by a deeper understanding of the SVZ’s profound impact on brain health and disease.

Funding Information:

Medical Scientific Research Foundation of Guangdong Province, China A2022125
Medical Scientific Research Foundation of Guangdong Province, China A2023486
Medical Research Fund of the Qingyuan People's Hospital 15001019002213
National Natural Science Foundation of China 82203351
Guangdong Basic and Applied Basic Research Foundation of China 2021A1515111095

# # # # #

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 7.3
Impact Factor: 6.9

# # # # # #

More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases ).
Submissions to Genes & Disease may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx ).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: [email protected]
X (formerly Twitter): @GenesNDiseases (https://x.com/GenesNDiseases )

# # # # # #
Reference
Kaishu Li, Yin Zheng, Shubing Cai, Zhiming Fan, Junyi Yang, Yuanrun Liu, Shengqi Liang, Meihui Song, Siyuan Du, Ling Qi, The subventricular zone structure, function and implications for neurological disease, Genes & Diseases, Volume 12, Issue 3, 2025, 101398, https://doi.org/10.1016/j.gendis.2024.101398

Genes & Diseases Editorial Office
Genes & Diseases
+ +86 23 6571 4691
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.